Michael Willis

Years Active: 2017-2022
Publications (10 Years): 6

University of California at Santa Barbara (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of California at Santa Barbara

United States

PHD :: Economics

Publications

Nikolaos Kotsopoulos, Mark P Connolly, Michael Willis, Andreas Nilsson, Åsa Ericsson, James Baker-Knight
The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs. Diabetes, obesity & metabolism 24 (6) (2022)
Jenny M Norlin, Michael Willis, Ulf Persson, Emelie Andersson, Sven E Pålhagen, Per Odin
Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementation. Acta neurologica Scandinavica 144 (2) (2021)
Michael Willis, Christian Asseburg, April Slee, Andreas Nilsson, Cheryl Neslusan
Macrovascular Risk Equations Based on the CANVAS Program. PharmacoEconomics 39 (4) (2021)
Michael Willis, Adam Fridhammar, Jens Gundgaard, Andreas Nilsson, Pierre Johansen
Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM. PharmacoEconomics 38 (9) (2021)
Winde Jorissen, Lieven Annemans, Nicolas Louis, Andreas Nilsson, Michael Willis
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium. Acta clinica Belgica 77 (6) (2021)
Michael Willis, Pierre Johansen, Andreas Nilsson, Christian Asseburg
Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM). PharmacoEconomics 35 (3) (2017)

Michael Willis.css-eqlu8i{font-size:small;padding-left:4px;}